Skip to content
Methodology
All entries for: NGGT INC.
August 14, 2025
NGGT INC.
Orphan Drug Designation
FDA orphan drug designation: treatment of homozygous familial hypercholesterolemia
Disease Area:
Rare Diseases
Source
Scroll to Top
